UNSPSC 51131802: Antihemophilic factor or globulin

This classification denotes coagulation factor VIII, a procoagulant component,a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 839MOZ74GK. European Medicines Agency schedules Antihemophilic Factor in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13813MIG.

UNSPSC 51131802 Antihemophilic factor or globulin is a Commodity code that nominally addresses blood clotting factors used in hemophilia treatment. The recent state and local opportunity record shows no relevant procurement activity under this code; the single posted opportunity (Sourcewell RFP #061626, due June 16, 2026) solicits law enforcement equipment through a cooperative purchasing vehicle, which falls outside the scope of pharmaceutical blood products and indicates a tagging mismatch rather than genuine market activity for antihemophilic factors in state and local procurement.

Without substantive recent solicitations tagged to this code, no issuing-body mix, geographic concentration, or representative opportunities in the hemophilia-treatment space can be characterized from the source material.